(Reuters) -Drugmaker Mallinckrodt said on Tuesday it has emerged from bankruptcy and reduced its total funded debt by about $1.9 billion. Mallinckrodt, which won court approval for its bankruptcy plan …
drugmaker
-
-
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Deliberations are ongoing and …
-
(Reuters) – Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids, the Wall Street Journal reported on Wednesday. …
-
By Joe Cash and Brenda Goh BEIJING (Reuters) – Global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said …
-
ZURICH (Reuters) – Roche has bought 540,000 of its own shares, the company said on Friday, as a member of its controlling family group scaled back their investment in voting …
-
PARIS (Reuters) -French drugmaker Sanofi said it expected a positive boost to its third-quarter business results from movements on the currency markets, helped by the strength of the U.S. dollar …
-
By Michael Erman NEW YORK – The U.S. Senate Finance Committee is widening its investigation into the tax practices of U.S. drugmakers to include Amgen Inc, according to a letter …
-
By Nancy Lapid (Reuters) – Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and …
-
(Reuters) -Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the drugmaker’s fish-oil derived heart drug faces stiff competition from generic rivals in the United …
-
By Steven Scheer JERUSALEM -Teva Pharmaceutical Industries said on Wednesday it was bracing to pay as much as $3.6 billion in cash and medicine to settle thousands of lawsuits alleging …
-
– Belgian drugmaker Galapagos NV on Wednesday named former Johnson & Johnson senior executive Paul Stoffels as its chief executive officer, effective April 1. Stoffels was the chief scientific officer …
-
(This Dec. 30 story refiles to add dropped words “members of” in last paragraph) By Brendan Pierson NEW YORK – Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York …
-
– Drugmaker Endo International plc said on Tuesday it had agreed to pay up to $65 million to resolve claims by the state of Florida and local governments that the …
-
By Mathieu Rosemain PARIS – Drugmaker Sanofi is investing $180 million in French startup Owkin, whose predictive algorithms aim to improve the research and development of new cures against cancer, …